MRI opens door to better treatments for underdiagnosed atypical parkinsonian disorders
Short excerpt below. Click through to read at the original source.
An international study led by researchers from the Sant Pau Research Institute (IR Sant Pau) shows that advanced use of magnetic resonance imaging (MRI) allows much more accurate identification of patients with progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). These are two rare and clearly underdiagnosed atypical parkinsonian disorders.